Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease (Q44047703)

29 November 2017

title

Probucol affords neuroprotection in a 6-OHDA mouse model of Parkinson's disease (English)

1 reference

29 November 2017

1 reference

ChEBI release 2020-05-28

1 reference

8

1 reference

29 November 2017

author name string

Renata Pietsch Ribeiro

1

1 reference

29 November 2017

Eduardo Luiz Gasnhar Moreira

2

1 reference

29 November 2017

Danúbia Bonfanti Santos

3

1 reference

29 November 2017

Dirleise Colle

4

1 reference

29 November 2017

Alessandra Antunes Dos Santos

5

1 reference

29 November 2017

Kaite Cristiane Peres

6

1 reference

29 November 2017

Claudia Pinto Figueiredo

7

1 reference

29 November 2017

publication date

19 January 2013

1 reference

29 November 2017

published in

Neurochemical Research

1 reference

29 November 2017

volume

38

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

660-668

1 reference

Parkinson's disease. First of two parts

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Missing pieces in the Parkinson's disease puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Etiology of Parkinson's disease: Genetics and environment revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

The etiology of Parkinson's disease with emphasis on the MPTP story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Redox imbalance in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Glutathione--a review on its role and significance in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Neurotoxin-based models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Long-term probucol treatment prevents secondary cardiovascular events: a cohort study of patients with heterozygous familial hypercholesterolemia in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

The cholesterol-lowering drug probucol increases apolipoprotein E production in the hippocampus of aged rats: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Molecular basis of 6-hydroxydopamine-induced caspase activations due to increases in oxidative stress in the mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Central nervous system activity of the proanthocyanidin-rich fraction obtained from Croton celtidifolius in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Antioxidant enzymes and human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Glutathione pathways in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Oxidative and antioxidative potential of brain microglial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Peroxide detoxification by brain cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Ebselen protects against methylmercury-induced inhibition of glutamate uptake by cortical slices from adult mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Superoxide dismutase: the first twenty years (1968-1988)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Oxidative stress and the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Where are we with probucol: a new life for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-012-0965-0

Free radical-generated neurotoxicity of 6-hydroxydopamine

21 January 2018

1 reference

12 December 2020

Progress in Parkinson's disease

1 reference

12 December 2020

Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease

1 reference

12 December 2020

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 reference

12 December 2020

44 Glutathione peroxidase

1 reference

12 December 2020

Intricate regulation of tyrosine hydroxylase activity and gene expression

1 reference

12 December 2020

Serotonin neural adaptations to ontogenetic loss of dopamine neurons in rat brain.

1 reference

12 December 2020

When does Parkinson's disease begin? From prodromal disease to motor signs

1 reference

12 December 2020

Properties of catalase purified from a methanol-grown yeast, Kloeckera sp. 2201

1 reference

12 December 2020

Mitochondrial dysfunction in Parkinson's disease

1 reference

12 December 2020

Mechanism of 6-hydroxydopamine neurotoxicity.

1 reference

12 December 2020

Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro

1 reference

12 December 2020

1 reference

12 December 2020

Probucol, a superoxide free radical scavenger in vitro

1 reference

12 December 2020

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

12 December 2020

A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease.

1 reference

12 December 2020

Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay.

1 reference

12 December 2020

1 reference

12 December 2020

Glutathione reductase

1 reference

12 December 2020

The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutase

1 reference

12 December 2020

Intracerebroventricular injections in mice. Some methodological refinements

1 reference

12 December 2020

Model experiments on the molecular mechanism of action of 6-hydroxydopamine

1 reference

12 December 2020

Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11064-012-0965-0

Identifiers

DOI

1 reference

29 November 2017

1 reference